Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-007394
Filing Date
2023-10-25
Accepted
2023-10-25 15:05:06
Documents
80
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 2023 cardiff_i10q-063023.htm   iXBRL 10-Q 1187072
2 CERTIFICATION cardiff_ex3101.htm EX-31.1 12333
3 CERTIFICATION cardiff_ex3102.htm EX-31.2 12329
4 CERTIFICATION cardiff_ex3201.htm EX-32.1 4648
5 CERTIFICATION cardiff_ex3202.htm EX-32.2 4757
  Complete submission text file 0001683168-23-007394.txt   6604790

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdif-20230630.xsd EX-101.SCH 59195
7 XBRL CALCULATION FILE cdif-20230630_cal.xml EX-101.CAL 68264
8 XBRL DEFINITION FILE cdif-20230630_def.xml EX-101.DEF 226277
9 XBRL LABEL FILE cdif-20230630_lab.xml EX-101.LAB 348272
10 XBRL PRESENTATION FILE cdif-20230630_pre.xml EX-101.PRE 301173
74 EXTRACTED XBRL INSTANCE DOCUMENT cardiff_i10q-063023_htm.xml XML 1092591
Mailing Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169
Business Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169 844-628-2100
Cardiff Lexington Corp (Filer) CIK: 0000811222 (see all company filings)

EIN.: 841044583 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-49709 | Film No.: 231345389
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine